SynthesisBMC infectious diseases2026
Leptospirosis and its co-infections in India: prevalence, geographic distribution, and clinical implications.
Synthesis in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeptospirosis is a zoonotic disease prevalent in low and middle-income countries and tropical regions. It can be mimicked by endemic infectious diseases that present simultaneously, like dengue, malaria, melioidosis, or scrub typhus. However, there is a dearth of documented evidence about the frequency of coinfection, as well as related symptoms and mortality. The study aims to determine the frequency and geographical extent of coinfections in leptospirosis patients in India. METHODOLOGY: We systematically searched databases, including Scopus, PubMed, Embase, and Web of Science, for articles published between January 2010 and August 2024 assessing coinfections in leptospirosis patients in India. The eligible articles were evaluated for full text data extraction using a standardized methodology.
resultsOf 804 articles screened 39 studies were included; overall these reported on 1565 leptospirosis cases with 236 (15.1%) cases with coinfections. Of these, seven observational studies assessed coinfections in 1318 leptospirosis-positive cases, identifying 113 (8.6%) coinfections: most commonly dengue (79; 69.9%), followed by hepatitis E (15; 13.2%), typhoid (9; 7.9%), and malaria (9; 7.9%). The most coinfection cases were reported from New Delhi (29.6%), followed by Kerala (21.6%), Karnataka (14.4%), Uttar Pradesh (12.2%), and Tamil Nadu (5.5%). Common symptoms included fever, vomiting, icterus, headache, thrombocytopenia, and transaminitis. Cases with coinfection had poorer outcomes with increased mortality compared to cases with isolated infection.
conclusionIn India, leptospirosis can present with co-infections such as dengue, hepatitis E, malaria, typhoid, and scrub typhus, complicating diagnosis due to overlapping clinical features. These coinfections are associated with unfavorable outcomes, including multi-organ dysfunction and increased mortality. Early diagnostic testing in febrile patients and timely, appropriate treatment are essential to improve patient outcomes.
trial registrationClinical trial number: not applicable. Review protocol registration (Open Science Framework): DOI https://doi.org/10.17605/OSF.IO/AS9W5 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.